Immune therapy for hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Immune therapy for hepatocellular carcinoma.

Immune therapy for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q38552117

about

Comment on 'Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area'.T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.

P2860

Q41512508-2CC2A8FD-9A23-473D-8159-7F59086680E5 Q48770906-B7DDA71A-0076-47E8-8308-F85D9C15EC15

P2860

Immune therapy for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q38552117

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Immune therapy for hepatocellular carcinoma.

@en

type

label

Immune therapy for hepatocellular carcinoma.

@en

prefLabel

Immune therapy for hepatocellular carcinoma.

@en

P1433

Q38552117-F86F6D05-A212-4AAE-A544-F496E8D0F912

P1476

Q38552117-719D4BB2-4528-4131-9584-99F92DEA1BFC

P2093

Q38552117-0EFF985D-3D2F-4EB4-9340-F140EF7F6064

P2860

Q38552117-1A9B83A7-E0C7-43F2-B12A-5BDEF9DEC8E9

Q38552117-25B235F1-CF00-4BFE-8922-4817801214CF

Q38552117-26ABC609-600B-4CB4-BC0E-4950440D6DB2

Q38552117-3754C0E4-051F-4204-A5AD-16AAA7171083

Q38552117-3A474ADF-A1A6-478A-B363-1C9456891903

Q38552117-5A301DAE-F775-44DA-AFD7-B2257C05F2C2

Q38552117-634A612F-0948-429A-AEE4-09D18C1C316D

Q38552117-645760A8-5634-4E28-A23E-C13E0AB52AA5

Q38552117-6724AD05-BEA7-4E58-B239-5D693D5AF249

Q38552117-716777DC-B586-4542-958F-8E469F460DB1

P2888

Q38552117-BCEFBE35-4E9D-4264-80AB-6738E6C709E5

P304

Q38552117-E2704C4F-B0D0-4D70-A4A4-79989F5CA662

P31

Q38552117-EA8027AD-2695-4E2A-B22F-6F48EE7EA987

P356

Q38552117-FECBB4B5-226C-4E17-B450-6ECD0380E4D0

P478

Q38552117-45863651-A70A-4E10-BCCF-0459B300D683

P577

Q38552117-1BF21353-D258-40E6-A66B-79D52E7A2C3E

P6179

Q38552117-48FE922B-A404-4FA2-B7BF-EFF28CD9E7A4

P698

Q38552117-6DC1F121-71A5-46BE-A67F-48FFAA023B78

P356

S12072-013-9501-9

P1433

Hepatology international

P1476

Immune therapy for hepatocellular carcinoma.

@en

P2093

Yaron Ilan

http://www.w3.org/2001/XMLSchema#string

P2860

Natural killer T cell-mediated immunotherapy for malignant diseases.

Immune downregulation leads to upregulation of an antiviral response: a lesson from the hepatitis B virus.

Dendritic cells in innate immune responses against HIV.

Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma.

Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders

Immunotherapeutic strategies for hepatocellular carcinoma.

Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies.

Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.

Management of immune-related adverse events and kinetics of response with ipilimumab.

Innate immunity and HCV.

P2888

s12072-013-9501-9

P304

499-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-013-9501-9

http://www.w3.org/2001/XMLSchema#string

P478

8 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032140279

http://www.w3.org/2001/XMLSchema#string

P698

26201331

http://www.w3.org/2001/XMLSchema#string